2,500
Participants
Start Date
August 21, 2024
Primary Completion Date
July 31, 2029
Study Completion Date
November 30, 2039
Amplatzer™ Occlusion Devices
The Amplatzer™ Occluders are devices intended for the occlusion of multiple septal heart defects.
Epic™ Surgical Tissue Heart Valve devices
The Epic™ valves are indicated for patients requiring replacement of a diseased, damaged, or malfunctioning native aortic/mitral heart valve. It may also be used as a replacement for a previously implanted aortic/mitral prosthetic heart valve.
RECRUITING
A.O.U. Citta della Salute e della Scienza di Torino, Turin
RECRUITING
Deutsches Herzzentrum der Charité, Berlin
RECRUITING
IRCCS Policlinico San Donato - Cardio, San Donato Milanese
RECRUITING
Policlinico San Donato, San Donato Milanese
RECRUITING
Hospital Universitario de la Paz - Pediatrico, Madrid
RECRUITING
Schüchtermann-Schiller´sche Kliniken GmbH & Co. KG, Bad Rothenfelde
RECRUITING
Hopital Haut Leveque, Pessac
RECRUITING
CHRU Hopital de Pontchaillou, Rennes
RECRUITING
Städt. Klinikum Braunschweig gGmbH, Braunschweig
RECRUITING
Hospital Virgen de Rocio, Seville
RECRUITING
Tartu University Hospital, Tartu
RECRUITING
Azienda Ospedaliero Universitaria Pisana, Pisa
RECRUITING
Deutsches Herzzentrum München des Freistaates Bayern, München
RECRUITING
Centre Médico Chirurgical Marie Lannelongue, Le Plessis-Robinson
RECRUITING
Universitatsklinikum Jena, Jena
RECRUITING
Slaskie Centrum Chorob Serca, Zabrze
RECRUITING
Hospital Infantil Sant Joan De Deu, Esplugues de Llobregat
RECRUITING
Royal Brompton Hospital, London
RECRUITING
St. Thomas Hospital, London
Lead Sponsor
Abbott Medical Devices
INDUSTRY